Committee approval of Dr. Price nomination delayed

Jan. 31, 2017
Democratic members of the Senate Finance Committee have boycotted a Committee vote on the approval of Tom Price, MD, as secretary of the Department of Health and Human Services (HHS). The vote, which was scheduled for Jan. 31, has been postponed due to the boycott. The Committee rules require that at least one Democratic member must be present for the Committee to proceed.

Dr. Price, an orthopedic surgeon, previously served as congressman for Georgia’s 6th district and as House Budget Committee chair and would be the first physician to serve as secretary of HHS in nearly 25 years.

The American Academy of Dermatology Association (AADA) understands and appreciates that not all of its members are supportive of Dr. Price’s nomination. However, after thoughtful discussion, and prior to the delay of the committee vote, the AADA Board of Directors determined that it was in the best interest of the AADA and its members to send a letter of support for Dr. Price. The AADA has had a long-standing relationship with Dr. Price, who was a featured speaker at the AADA's 2012 Legislative Conference. Dr. Price has been a staunch supporter of several issues that impact dermatology. Specifically, Dr. Price has worked on issues such as Medicare payment reform, shortening EHR reporting periods, and ensuring that the MACRA transition included opportunities for physicians to avoid penalties. Dr. Price has also demonstrated a commitment to decreasing over-burdensome regulations associated with EHR, MACRA, and quality reporting. 

The AADA’s support at this critical point in the nomination process will help keep dermatology at the forefront of discussion as the new Administration works to address issues of concern. Read more from the AADA letter. For questions or concerns, contact